Medicine and Health

RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial

R. Wittoek, G. Verbruggen, et al.

This study by Ruth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, Roos Colman, and Dirk Elewaut explores the impact of denosumab on erosive hand osteoarthritis. Results show significant reductions in radiographic erosive progression and long-term clinical benefits after 96 weeks of treatment. Discover how this RANKL inhibitor could change the game in managing OA.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial

H. R. C. Shanks, K. Chen, et al.

Medicine and Health

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

P. Glue, C. Loo, et al.

Medicine and Health

A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial

A. H. Diacon, C. E. B. Iii, et al.

Medicine and Health

Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial

K. Mautner, M. Gottschalk, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny